BiRDS Pharma AG offers to pharmaceutical and biotech companies extensive consulting in all scientific, economic and regulatory aspects of drug development and approval. By making use of BiRDS Pharma AG´s drug development consulting services, the client at the same time gets access expertise and know how of all BDD/CCDRD Group affiliates and can also benefit from the expert network the Group is operating in. BiRDS Pharma AG was involved in the development and implementation of overall strategies for a variety of drug development projects by clients, including biosimilars, vaccines, and an innovative cytokine drug product for treatment of disorders associated to the immune system. Furthermore, BiRDS Pharma AG has proven expertise in regulatory consultancy for companies planning to enter the European market and has written a variety of expert reports for Dossiers submitted to German and European Authorities for Market Authorization of generic and innovative drug products. |
